The £3 million Tumour Profiling Unit (TPU) in London is to research the use of DNA mapping to identify patients' cancer strains. It is hoped the technique will pave the way for radical new forms of diagnosis, surveillance and targeted therapy.
One aim of the research is to develop "liquid biopsies" that search for free-floating cancer DNA in samples of blood. This can then be used to identify and monitor cancer sub-types that are likely to respond to particular drugs.
Another, controversial, proposal is the use of "mouse avatars" that mirror a patient's disease progression.
Tumour samples from patients will be implanted into mice which will then be observed closely to spot early signs of molecular change and resistance to therapy.
More top news
The United Nations has made a renewed and record-breaking global appeal, after falling well short of its last request for financial help.
It used to be the most important club on the northern variety circuit, but since Bernard Manning's death the club no longer draws the crowds
After rain and wintry showers overnight, it will be sunny for much of the country tomorrow, but it will be colder.